Why Dentsply International (XRAY) is a Top Momentum Stock for the Long-Term

Dentsply International (XRAY), a global leader in dental products, is highlighted as a top momentum stock, holding a Zacks Rank #2 (Buy) and an 'A' VGM Score. The company's 'B' Momentum Style Score is supported by a 0.7% share price increase over the past four weeks and recent upward revisions from three analysts, raising the fiscal 2025 Zacks Consensus Estimate to $1.90 per share. This strong proprietary rating and positive earnings momentum suggest XRAY warrants investor consideration.

Analysis

DENTSPLY SIRONA Inc. (XRAY) is exhibiting positive momentum signals driven by upward revisions in earnings estimates, as highlighted by its Zacks Rank #2 (Buy) designation. This rating is supported by tangible analyst actions, with three analysts revising their fiscal 2025 earnings estimates higher within the last 60 days. Consequently, the Zacks Consensus Estimate for fiscal 2025 has increased by $0.03 to $1.90 per share. The stock also scores favorably on proprietary metrics, holding a composite VGM Score of 'A' and a Momentum Style Score of 'B'. While recent share price movement has been modest at a 0.7% gain over the past four weeks, the company has a track record of outperformance, boasting an average earnings surprise of +2.7%. These factors collectively point to strengthening forward-looking expectations for the dental products leader.

Key Decisions for Investors

• Investors with a momentum-based strategy should consider XRAY, given its strong proprietary ratings and the positive trend in analyst earnings revisions for fiscal 2025.
• It is crucial to monitor whether the positive earnings estimate revisions continue, as this trend is the primary driver for the current bullish thesis presented.
• Given the analysis is based on a specific quantitative rating system, investors may find it prudent to corroborate these signals with independent fundamental research before altering a position.